[{"address1": "Rue du Centre 172", "city": "Saint-Sulpice", "zip": "1025", "country": "Switzerland", "phone": "41 21 694 10 60", "website": "https://www.sophiagenetics.com", "industry": "Health Information Services", "industryKey": "health-information-services", "industryDisp": "Health Information Services", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharma customers worldwide. The company was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.", "fullTimeEmployees": 466, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jurgi  Camblong M.B.A., Ph.D.", "age": 45, "title": "Co-Founder, CEO & Director", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": 1105546, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ross Jordan Muken B.Sc.", "age": 42, "title": "Executive VP, CFO & COO", "yearBorn": 1981, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Abhimanyu  Verma", "title": "Senior VP & CTO", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zhenyu  Xu Ph.D.", "age": 40, "title": "Executive VP & Chief Scientific Officer", "yearBorn": 1983, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katherine  Bailon", "title": "Vice President of Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daan  van Well L.L.M., M.B.A.", "age": 49, "title": "Executive VP, Chief Legal & Compliance Officer", "yearBorn": 1974, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Manuela Da Silva Valente B.A.", "age": 52, "title": "Senior VP & Chief People Officer", "yearBorn": 1971, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Puylaert", "title": "VP & MD of EMEA", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philippe  Menu M.B.A., M.D., Ph.D.", "age": 41, "title": "Executive VP, Chief Medical Officer & Chief Product Officer", "yearBorn": 1982, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Casasanto", "title": "Senior VP & Chief BioPharma Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 5.01, "open": 5.1, "dayLow": 4.88, "dayHigh": 5.22, "regularMarketPreviousClose": 5.01, "regularMarketOpen": 5.1, "regularMarketDayLow": 4.88, "regularMarketDayHigh": 5.22, "beta": 1.184, "forwardPE": -7.4477606, "volume": 32567, "regularMarketVolume": 32567, "averageVolume": 45823, "averageVolume10days": 81350, "averageDailyVolume10Day": 81350, "bidSize": 3100, "askSize": 1300, "marketCap": 325853984, "fiftyTwoWeekLow": 2.13, "fiftyTwoWeekHigh": 7.37, "priceToSalesTrailing12Months": 5.5505133, "fiftyDayAverage": 4.84904, "twoHundredDayAverage": 3.895935, "currency": "USD", "enterpriseValue": 251142880, "profitMargins": -1.17347, "floatShares": 46723747, "sharesOutstanding": 65301400, "sharesShort": 60601, "sharesShortPriorMonth": 57800, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.00090000004, "heldPercentInsiders": 0.04788, "heldPercentInstitutions": 0.5017, "shortRatio": 2.33, "shortPercentOfFloat": 0.0013, "impliedSharesOutstanding": 65301400, "bookValue": 2.433, "priceToBook": 2.0509658, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -68891000, "trailingEps": -1.2, "forwardEps": -0.67, "enterpriseToRevenue": 4.278, "enterpriseToEbitda": -3.694, "52WeekChange": 0.44797683, "SandP52WeekChange": 0.3219322, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "SOPH", "underlyingSymbol": "SOPH", "shortName": "SOPHiA GENETICS SA", "longName": "SOPHiA GENETICS SA", "firstTradeDateEpochUtc": 1627047000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f918cd23-5350-3327-9bee-4d9c556b1784", "messageBoardId": "finmb_237555193", "gmtOffSetMilliseconds": -18000000, "currentPrice": 4.99, "targetHighPrice": 10.0, "targetLowPrice": 8.0, "targetMeanPrice": 8.67, "targetMedianPrice": 8.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 132767000, "totalCashPerShare": 2.038, "ebitda": -67989000, "totalDebt": 17868000, "quickRatio": 4.938, "currentRatio": 5.302, "totalRevenue": 58707000, "debtToEquity": 11.278, "revenuePerShare": 0.91, "returnOnAssets": -0.19414, "returnOnEquity": -0.37818, "freeCashflow": -34254000, "operatingCashflow": -47612000, "revenueGrowth": 0.4, "grossMargins": 0.69232005, "ebitdaMargins": -1.15811, "operatingMargins": -1.0147799, "financialCurrency": "USD", "trailingPegRatio": null}]